| CreditFlow: End of Day (Europe IG) | Nov 16, 2026 |
| CreditFlow: End of Day (Europe IG) | Sep 23, 2026 |
| CreditFlow: End of Day (Europe IG) | Sep 14, 2026 |
| CreditFlow: End of Day (Europe IG) | Aug 27, 2026 |
| CreditFlow: End of Day (Europe IG) | Aug 24, 2026 |
| CreditFlow: End of Day (Europe IG) | Jun 12, 2026 |
| CreditFlow: End of Day (Europe IG) | Jun 2, 2026 |
| CFR CREDIT CLOSE: Novartis $11bn Headlines $25.95bn Session as IG Clears $600bn | Mar 16, 2026 |
| CFR CREDIT CLOSE: Week Tops Estimates, 2nd Largest Deal Week '26 | Feb 25, 2026 |
| CFR CREDIT CLOSE: New November Record = Month Record Trifecta; Year Tops $1.6trn | Nov 18, 2025 |
| Industry | Status | Date | Ticker(s) | issuer(s) | MO | SP | FI | Size (M) | Ranking | TNR | Call | MTY | Coupon | Leads | product | Market | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
HLTH | PRCD | Nov 16, 2026 | MRKGR | Merck Financial Services GmbH | A3 | A | - | €700 | Sr. Unsecured | 2.00 | - | Nov-28 | 3mE+43 | BBV, BNP, ... | IGC | European | |||
HLTH | PRCD | Nov 16, 2026 | MRKGR | Merck Financial Services GmbH | A3 | A | - | €900 | Sr. Unsecured | 4.50 | - | May-31 | 3.875% | BBV, BNP, ... | IGC | European | |||
HLTH | PRCD | Nov 16, 2026 | MRKGR | Merck Financial Services GmbH | A3 | A | - | €1,050 | Sr. Unsecured | 7.00 | - | Nov-33 | 4.125% | BBV, BNP, ... | IGC | European | |||
HLTH | PRCD | Nov 16, 2026 | MRKGR | Merck Financial Services GmbH | A3 | A | - | €1,050 | Sr. Unsecured | 10.00 | - | Nov-36 | 4.25% | BBV, BNP, ... | IGC | European | |||
HLTH | PRCD | Sep 23, 2026 | BAYNGR | Bayer AG | Baa3 | BB+ | BB+ | €1,000 | Subordinated | 30.00 | 6.00 | Sep-56 | 5.75% | BAM, BNP, ... | IGC | European | |||
HLTH | PRCD | Sep 23, 2026 | BAYNGR | Bayer AG | Baa3 | BB+ | BB+ | €1,000 | Subordinated | 30.00 | 9.00 | Sep-56 | 6.25% | BAM, BNP, ... | IGC | European | |||
HLTH | PRCD | Sep 14, 2026 | SDZSW | Sandoz Finance BV | Baa2 | BBB | - | €500 | Sr. Unsecured | 12.00 | - | Sep-38 | 4.835% | BAM, MIZ, ... | IGC | European | |||
HLTH | PRCD | Aug 27, 2026 | GSK | GSK Capital BV | A2 | A | - | €850 | Sr. Unsecured | 1.50 | - | Mar-28 | 3mEu+30 | BAM, BNP, ... | IGC | European | |||
HLTH | PRCD | Aug 27, 2026 | GSK | GSK Capital BV | A2 | A | - | €1,000 | Sr. Unsecured | 4.00 | - | Sep-30 | 3.50% | BAM, BNP, ... | IGC | European | |||
HLTH | PRCD | Aug 27, 2026 | GSK | GSK Capital BV | A2 | A | - | €850 | Sr. Unsecured | 8.00 | - | Sep-34 | 3.875% | BAM, BNP, ... | IGC | European |